Relapsing Babesiosis With Molecular Evidence of Resistance to Certain Antimicrobials Commonly Used to Treat Babesia microti Infections

Human babesiosis cases are emerging with an increased incidence and a wider geographic range worldwide. Relapsing babesiosis cases are becoming more frequently encountered in clinical practice associated with the use of immunosuppressive medications. The 2020 Infectious Diseases Society of America b...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcos, Luis A, Wormser, Gary P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394720/
https://www.ncbi.nlm.nih.gov/pubmed/37539067
http://dx.doi.org/10.1093/ofid/ofad391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394720/
https://www.ncbi.nlm.nih.gov/pubmed/37539067
http://dx.doi.org/10.1093/ofid/ofad391

Ejemplares similares